Renal Artery Stent Market Report
First published: 21 October 2024 | Last updated: 25 May 2026 | Report Code: renal-artery-stent
Renal Artery Stent Market — USD 2.5 billion in 2023, Growing to USD 4.91B by 2033 at 6.8% CAGR
This report provides a comprehensive analysis of the Renal Artery Stent market, focusing on current trends, market size, projections for growth, and challenges within the industry from 2023 to 2033.
Key Takeaways
- Global market projected to rise from $2.50 Billion in 2023 to $4.91 Billion in 2033 at a 6.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe is expected to expand from $0.83 Billion in 2023 to $1.63 Billion in 2033, reflecting steady regional demand.
- Product categories covered include Metal Stents, Drug-Eluting Stents, and Bioresorbable Stents, with multiple delivery routes and end-users presented.
- Leading companies profiled include Boston Scientific Corporation, Medtronic, Abbott Laboratories, B. Braun, and Terumo Corporation.
Renal Artery Stent Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines the renal artery stent market across product types, applications, delivery routes, and end-users. Market size is $2.50 Billion in 2023 and is forecast to reach $4.91 Billion in 2033 with a 6.8% CAGR from 2023 to 2033. Key growth catalysts include rising prevalence of renal vascular conditions, preference for minimally invasive interventions, and ongoing device innovation. Coverage includes segmentation by product—Metal Stents, Drug-Eluting Stents, Bioresorbable Stents—applications such as ischemic nephropathy and renal artery stenosis, and delivery routes including percutaneous and surgical intervention. Regional breakdown details North America as the largest market, with Europe, Asia Pacific, Latin America, and Middle East and Africa also profiled using start and end period values. Competitive analysis highlights major participants such as Boston Scientific Corporation, Medtronic, Abbott Laboratories, B. Braun, and Terumo Corporation. Methodology combines primary expert interviews with secondary literature and internal validation to support findings and trend interpretation.
Key Growth Drivers
- Increasing incidence of renal vascular conditions drives demand for endovascular interventions over open surgery.
- Advances in stent materials and drug-eluting technologies improve procedure outcomes and broaden clinical indications.
- Shift toward minimally invasive percutaneous procedures encourages adoption across hospitals and ambulatory surgical centers.
- Ongoing R&D and device approvals by established manufacturers support new product introductions and market expansion.
- Rising awareness and screening for renal artery disorders increase case detection and treatment rates.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | Boston Scientific Corporation, Medtronic , Abbott Laboratories, B. Braun, Terumo Corporation |
| Published Date | 21 October 2024 |
| Last Modified Date | 25 May 2026 |
Renal Artery Stent Market Overview
Customize Renal Artery Stent Market Report market research report
- ✔ Get in-depth analysis of Renal Artery Stent market size, growth, and forecasts.
- ✔ Understand Renal Artery Stent's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Renal Artery Stent
What is the Market Size & CAGR of Renal Artery Stent Market Report market in 2023?
Renal Artery Stent Industry Analysis
Renal Artery Stent Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Renal Artery Stent Market Report Market Analysis Report by Region
Europe Renal Artery Stent Market Report:
Europe grows from $0.83 Billion in 2023 to $1.63 Billion in 2033. The region's progress reflects clinical guideline adoption for vascular interventions, increasing screening, and device innovation among regional and global players.Asia Pacific Renal Artery Stent Market Report:
Asia Pacific grows from $0.47 Billion in 2023 to $0.92 Billion in 2033. Expansion is driven by rising diagnosis rates, growing access to interventional procedures, and investment in healthcare infrastructure and training.North America Renal Artery Stent Market Report:
North America is largest regional market, rising from $0.91 Billion in 2023 to $1.78 Billion in 2033. Market momentum is underpinned by established clinical adoption of endovascular therapies, reimbursement frameworks, and active participation of major manufacturers.South America Renal Artery Stent Market Report:
Latin America grows from $0.1 Billion in 2023 to $0.2 Billion in 2033. Growth factors include improving procedural access and a gradual uptake of minimally invasive vascular interventions in select healthcare centers.Middle East & Africa Renal Artery Stent Market Report:
Middle East and Africa grows from $0.19 Billion in 2023 to $0.38 Billion in 2033. Regional development is supported by targeted healthcare investments, expanding specialist services, and interest in advanced device options.Tell us your focus area and get a customized research report.
Research Methodology
Renal Artery Stent Market Analysis By Product Type
The product types in the Renal Artery Stent market include metal stents, drug-eluting stents, and bioresorbable stents. Metal stents dominate this segment, accounting for 87.36% of the market in 2023 and projected to hold the same share in 2033, driven by their reliability and long-term performance. Drug-eluting stents are also gaining traction for their ability to reduce restenosis rates.
Renal Artery Stent Market Analysis By Application
The main applications encompass ischemic nephropathy, renal artery stenosis, and other indications. Ischemic nephropathy represents the largest share, holding 65.91% of the market in 2023 and maintaining this share through 2033. The growing patient population requiring effective therapies for renal artery stenosis is also significant, as it accounted for 25.49% of the market.
Renal Artery Stent Market Analysis By Delivery Route
In terms of delivery routes, percutaneous interventions hold a dominating market share of 87.36% in 2023 and will continue to do so into 2033. The non-invasive nature of these procedures ensures quick recovery times, making them preferable among healthcare providers and patients.
Renal Artery Stent Market Analysis By End User
The market can be segmented into hospitals, specialty clinics, and ambulatory surgical centers. Hospitals account for the majority share, comprising 65.91% in 2023. Specialty clinics and ambulatory surgical centers are also vital as they cater to specific procedures that require less overhead compared to traditional settings.
Renal Artery Stent Market Analysis By Material
The materials used in the production of renal artery stents include metals and polymers. Metal stents maintain a significant market share of 87.36% in 2023, attributed to their durability and effectiveness. Alternatively, polymer stents, while emerging, hold a smaller share of 12.64% but are expected to grow within the coming decade.
Renal Artery Stent Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Renal Artery Stent Industry
Boston Scientific Corporation:
A leading global developer of medical devices, Boston Scientific is at the forefront of innovation in renal artery stents, focusing on user-friendly designs and advanced materials.Medtronic :
Known for its diverse portfolio, Medtronic provides advanced stenting solutions and is heavily involved in ongoing research to enhance treatment efficacy for renal diseases.Abbott Laboratories:
Abbott specializes in drug-eluting stents and aggressively pursues investments in renal technologies to alleviate the burden of kidney-related health issues worldwide.B. Braun:
B. Braun has a presence in the renal industry with a focus on providing high-quality medical devices and has contributed significantly to the growth of stent design innovation.Terumo Corporation:
Terumo is a pioneer in healthcare innovation and has introduced several critically acclaimed devices, including advanced renal artery stents.We're grateful to work with incredible clients.
FAQs
What is the market size in 2023?
The renal artery stent market size in 2023 is $2.50 Billion, as reported in the study covering the 2023 to 2033 forecast period.
How big will the market be in 2033?
The market is projected to reach $4.91 Billion by 2033 according to the forecast provided for the 2023 to 2033 period.
What is CAGR for the forecast period?
The compound annual growth rate for the market over the 2023 to 2033 forecast period is 6.8% as specified in the report.
Is there a single fastest Growing region in the Renal Artery Stent Market Report market?
No single fastest-growing region is stated for the Renal Artery Stent Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which product types are included?
The report covers Metal Stents, Drug-Eluting Stents, and Bioresorbable Stents as primary product-type categories.
Who are the leading companies profiled?
Top companies included in the competitive overview are Boston Scientific Corporation, Medtronic, Abbott Laboratories, B. Braun, and Terumo Corporation.
What are common delivery routes covered?
Delivery routes addressed include Percutaneous approaches and Surgical Intervention options across clinical settings.
How big is the Europe market in the period?
Europe increases from $0.83 Billion in 2023 to $1.63 Billion in 2033, as identified in the regional data supplied.
What drives product innovation in this sector?
Product innovation is driven by material science advances, drug-eluting technologies, and the push for improved clinical outcomes and device safety.
How big is the Asia Pacific market in 2023 and 2033?
Asia Pacific is reported at $0.47 Billion in 2023 and grows to $0.92 Billion in 2033 according to provided regional figures.